Science|Business
Reports
Rates
Non-Members
Price: FREE
Science|Business Members
Price: FREE

Make sure you login to get this price.

Is your organisation a member? Check here.
If so, click here to find out how to receive your copy. If not, please join our network as an individual member to get this and other benefits.
Support
Please contact us at orders@sciencebusiness.net or +32 2304 7577 if you need any assistance.
Horizon 2020 Special Coverage
Academic Enterprise Awards (ACES) 2013
The ACES - Academic Enterprise Awards - are the only pan-European awards for spin-out companies emerged from European universities and public research centres.
European Parliament, Brussels - 04 June 2013
Smarter Data for Europe: Live webcast with Vice-President Neelie Kroes
The development of ‘Big Data’ applications and e-infrastructure can stimulate a new wave of economic and social progress.
Park Royal, Brussels - 23 May 2013
Horizon 2020 Guide: Bigger, Simpler, Bolder
A guide to Europe’s multi-billion Horizon 2020 innovation plan, and its journey through the EU legislature.
Horizon 2020 Guide: Bigger, Simpler, Bolder
A guide to Europe’s multi-billion Horizon 2020 innovation plan, and its journey through the EU legislature.
New ideas for managing scarce resources and energy
Report of a high-level academic policy debate on resource innovation, containing key ideas and recommendations on how to manage scarce resources and energy in Europe.
Pages: 26
Unlocking the value of Personalised Healthcare in Europe

This new study shows ICT investments could cut healthcare costs for key ailments by more than 35%.


info
What is personalised healthcare? A methodology – enabled by modern genetic, biopharma, diagnostic and ICT technologies that attempts to tailor the treatment to the individual patient. Rather than one-pill-fits-all, doctors use growing knowledge of the human genome, and of other biomarkers of health and disease, to offer targeted prevention measures and to optimise treatment strategies. No one is suggesting treatment is not alr eady personal, in that healthcare professionals make an assessment of each patient before deciding how to treat them. But the tools of personalised healthcare provide deeper insights and allow treatments to be more finely honed to individual needs.

The end result will be greater effectiveness, fewer side effects, longer and healthier lives, and more sustainable healthcare syste ms. The barriers include technology, financing, cost and change management. Personalised medicine is already in use in a few fields including oncology, cardiology, rare diseases. But introduction and uptake is still slow, not least in Europe.
info
Advertisement